Search company, investor...

Predict your next investment

Yunfeng Capital company logo
Private Equity
yfc.cn

Investments

178

Portfolio Exits

35

Funds

6

About Yunfeng Capital

Yunfeng Capital is a private equity firm in China.

Headquarters Location

Room 3501, 35th floor, K. Wah Centre, No. 1010 Middle Huaihai Rd.

Shanghai, Shanghai,

China

+8621-31270909

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Research containing Yunfeng Capital

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Yunfeng Capital in 1 CB Insights research brief, most recently on Nov 10, 2021.

Latest Yunfeng Capital News

Alibaba confirms Hong Kong IPO plan for logistics unit

Sep 27, 2023

Send to Alibaba Group’s logistics unit has filed for an IPO in Hong Kong, potentially creating liquidity events for private equity backers such as Yunfeng Capital, Primavera Capital Group, and Princeville Global, as well as for GIC, Temasek Holdings, and Khazanah Nasional. Alibaba owns 69.54% of Cainiao Smart Logistics Group and it expects to retain more than 50% following the spin-off via IPO, according to a filing.Guojun Shen, the founder of Chinese real estate and... To continue reading...

Yunfeng Capital Investments

178 Investments

Yunfeng Capital has made 178 investments. Their latest investment was in Robosense as part of their Series G on April 01, 2023.

CBI Logo

Yunfeng Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/1/2023

Series G

Robosense

$164.41M

No

2

3/20/2023

Series B - II

Etana Biotechnologies

$8M

No

2

2/23/2023

Series A

HaoDyne Technology

$21.7M

Yes

3

9/28/2022

Series B

Subscribe to see more

Subscribe to see more

10

8/16/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/1/2023

3/20/2023

2/23/2023

9/28/2022

8/16/2022

Round

Series G

Series B - II

Series A

Series B

Series A

Company

Robosense

Etana Biotechnologies

HaoDyne Technology

Subscribe to see more

Subscribe to see more

Amount

$164.41M

$8M

$21.7M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

2

3

10

10

Yunfeng Capital Portfolio Exits

35 Portfolio Exits

Yunfeng Capital has 35 portfolio exits. Their latest portfolio exit was Robosense on January 05, 2024.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/5/2024

IPO

$99M

Public

4

12/19/2023

IPO

$99M

Public

4

10/12/2023

IPO

$99M

Public

2

3/15/2023

IPO

Subscribe to see more

$99M

Subscribe to see more

10

12/15/2022

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/5/2024

12/19/2023

10/12/2023

3/15/2023

12/15/2022

Exit

IPO

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Public

Subscribe to see more

Subscribe to see more

Sources

4

4

2

10

10

Yunfeng Capital Acquisitions

11 Acquisitions

Yunfeng Capital acquired 11 companies. Their latest acquisition was AbelZeta Pharma on February 20, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/20/2021

Series A

$99M

$120M

Take Private

2

3/11/2019

$99M

Acquired

7

1/18/2019

$99M

Take Private

8

7/4/2018

Other

Subscribe to see more

$99M

$99M

Subscribe to see more

10

12/8/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/20/2021

3/11/2019

1/18/2019

7/4/2018

12/8/2017

Investment Stage

Series A

Other

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$120M

$99M

Note

Take Private

Acquired

Take Private

Subscribe to see more

Subscribe to see more

Sources

2

7

8

10

10

Yunfeng Capital Fund History

6 Fund Histories

Yunfeng Capital has 6 funds, including Yunfeng IK Co-invest.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/16/2019

Yunfeng IK Co-invest

$50M

3

8/3/2018

Yunfeng Fund III

Subscribe to see more

Subscribe to see more

$99M

10

5/28/2014

Yunfeng Fund II

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2010

Yunfeng Fund

Subscribe to see more

Subscribe to see more

$99M

10

Yunfeng Fund III

$99M

10

Closing Date

1/16/2019

8/3/2018

5/28/2014

12/31/2010

Fund

Yunfeng IK Co-invest

Yunfeng Fund III

Yunfeng Fund II

Yunfeng Fund

Yunfeng Fund III

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$50M

$99M

$99M

$99M

$99M

Sources

3

10

10

10

10

Yunfeng Capital Team

10 Team Members

Yunfeng Capital has 10 team members, including , .

Name

Work History

Title

Status

David Yu

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

David Yu

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.